## BACKGROUND. The activity of the combination of carboplatin and liposomal doxorubicin was tested in a Phase II study of patients with recurrent cervical carcinoma. ## METHODS. The combination of carboplatin (area under the concentration curve [AUC], 5) and liposomal doxorubicin (Doxil; starti
Methyl-CCNU, doxorubicin, and cis-diaminedichloroplatinum II in the management of recurrent and metastatic squamous carcinoma of the cervix
โ Scribed by Byron J. Masterson; John A. Carlson Jr; Thomas G. Day; Joseph C. Allegra; Thomas M. Woodcock; Richard A. Greenberg
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 423 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Patients with metastatic carcinoma of the uterine cervix have limited survival. thus, new chemotherapeutic agents and combinations are needed to improve patient outcome. ## Methods: Twenty-seven patients with stage iv primary or recurrent carcinoma of the uterine cervix were assign
## Phase II Trial of Weekly Locoregional Hyperthermia and Cisplatin in Patients with a Previously Irradiated Recurrent Carcinoma of the Uterine Cervix BACKGROUND. The biologic rationale for combining cisplatin with locoregional Ron C